Dermatology Practice for Sale

Dermatology has become the crown jewel of healthcare private equity. If you're considering selling your derm practice, you're entering one of the most active—and lucrative—specialty M&A markets in medicine.

This guide covers why dermatology commands premium valuations, who's buying, and how to position your practice for maximum value.

Why Private Equity Loves Dermatology

There's a reason dozens of PE-backed platforms are competing aggressively for derm practices. The specialty has nearly perfect economics for consolidation:

High Margins, Low Capital Requirements

Dermatology generates strong EBITDA margins (often 25-40%) without the capital intensity of specialties that require expensive imaging or surgical facilities. An exam room, a well-trained MA, and a dermatoscope can produce significant revenue.

Predictable, Recurring Revenue

Acne patients, psoriasis management, annual skin checks—dermatology has built-in recurring patient relationships. This predictability is exactly what PE investors want.

Multiple Revenue Streams

A single derm practice can capture:

• Medical dermatology Covered by insurance, stable volume
• Mohs surgery High-acuity, high-margin procedures
• Cosmetic services Cash-pay, margin expansion
• Pathology In-house lab captures additional revenue per case

Fragmented Market

The vast majority of derm practices are still independent. That's a buying opportunity for platforms seeking to aggregate.

Favorable Demographics

Aging population = more skin cancer. Sun damage awareness = more prevention visits. The demand curve is going up.

Current Dermatology Valuation Multiples

Here's what you can expect in 2026:

Note: These are general ranges. Your specific multiple depends on financial performance, growth trajectory, payer mix, and market conditions.

Who's Buying Dermatology Practices?

The buyer landscape is dominated by PE-backed Management Services Organizations (MSOs). Here's the current competitive environment:

Private Equity Platforms (Primary Buyers)

Over 30 PE-backed derm platforms are actively acquiring practices. Major players include nationally-scaled platforms as well as regional groups building critical mass. These buyers offer the highest multiples but require post-sale employment commitments (typically 3-5 years).

Strategic Health Systems

Some hospital systems are building or acquiring derm capacity to capture referrals and maintain market share. Usually lower multiples than PE, but may offer different lifestyle trade-offs.

Individual Physician Buyers

Increasingly rare for dermatology given high valuations. Financing a 7x+ acquisition is challenging for an individual buyer. More common for smaller practices without PE appeal.

What Buyers Look For in a Derm Practice

Revenue Mix

• Mohs volume: High-margin cases that drive EBITDA
• Cosmetic percentage: Cash-pay revenue less exposed to payer pressure
• Medical derm base: Stable, recurring patient relationships

Provider Composition

• Multiple providers preferred: Reduces key-man risk
• APP leverage: NPs and PAs extending physician capacity
• Employed vs. partnership model: Simpler integration for employed

Operational Metrics

• Patients per day per provider: Efficiency measure
• Revenue per visit: Indicator of revenue capture
• Payer mix: Commercial vs. Medicare mix affects margins

Market Position

• Geographic location: Coastal and Sun Belt markets command premiums
• Competition density: Underserved markets are more attractive
• Referral relationships: Primary care referral network strength

Preparing Your Derm Practice for Sale

To maximize your multiple, focus on these areas 12-24 months before going to market:

Financial Preparation

• Clean your books. 3 years of clear financial statements, P&Ls, and tax returns. Reconcile everything.
• Document add-backs. Personal expenses, one-time costs, above-market owner comp—make sure it's all documented and defensible.
• Track revenue by service line. Buyers want to see Mohs, cosmetic, and medical derm breakdowns.

Operational Preparation

• Reduce key-man risk. If you're the only provider, that limits your multiple. Consider adding an associate or APP.
• Secure your lease. Get 5+ years of runway with reasonable terms.
• Systematize operations. SOPs, employee handbooks, documented processes— buyers want a turnkey operation.

Growth Initiatives

• Maintain or grow volume. No buyer wants to catch a declining knife.
• Optimize revenue capture. Are you billing correctly for all services?
• Consider cosmetic expansion. Even a modest cosmetic offering can add a premium to your multiple.

The Sale Process Timeline

Total timeline: 6-12 months from decision to close. Rushing the process leaves value on the table.

What to Expect Post-Sale

Most PE deals require physician sellers to continue working for 3-5 years under an employment agreement. Here's what that typically looks like:

• Guaranteed salary: Usually close to your historical collections, sometimes with productivity bonuses
• Clinical autonomy: Generally maintained, though with some operational standardization
• Administrative relief: The MSO handles HR, billing, marketing, and back office—you focus on patients
• Rollover equity: 10-30% of proceeds "rolled" into the platform for a "second bite" when the platform sells

Common Mistakes in Derm M&A

• Talking to only one buyer. Competition creates leverage. Run a process.
• Undervaluing cosmetic revenue. Cash-pay services are worth more than insurance reimbursement—make sure it's reflected.
• Ignoring the employment agreement. A below-market salary subsidizes the purchase price. Negotiate hard.
• Rushing the process. Preparation adds 1-2x to your multiple. Take the time.
• Forgetting about rollover. That 20% holdback is real money—understand the platform's trajectory.

Next Steps

• Selling to Private Equity: How PE deals work and what to expect
• Selling Dermatology to an MSO: Specific guidance for MSO transactions
• Medical Practice Valuation: Deep dive into how buyers calculate value
• How to Sell a Medical Practice: Complete guide to the sale process